loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for MolPort-001-794-015

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    MolPort-001-794-015

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 35Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Valeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin
    Valeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin

    12 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/valeo-pharma-highlights-mdbriefcase-newsletter-comparing-hesperidin-and-vitamin-c-for-covid-19-301206174.html

    PRNEWSWIRE
    12 Jan 2021
    Share Share
    FDA has no objections to GRAS status of Spanish firm’s hesperidin
    FDA has no objections to GRAS status of Spanish firm’s hesperidin

    11 Mar 2019

    // Adi Menayang NUTRAINGREDIENT

    https://www.nutraingredients-usa.com/Article/2019/03/11/FDA-has-no-objections-to-GRAS-status-of-Spanish-firm-s-hesperidin

    Adi Menayang NUTRAINGREDIENT
    11 Mar 2019
    Share Share
    Anvisa Suspends Kern Pharma's Perivasc Drug
    Anvisa Suspends Kern Pharma's Perivasc Drug

    17 Jun 2017

    // ANVISA

    https://www.pharmacompass.com/pdf/news/anvisa-suspends-kern-pharmas-perivasc-drug-1497675346.pdf

    ANVISA
    17 Jun 2017
    Share Share
    Body Plus Nutritional Products Inc Recalls of Precision Extreme Mega Test
    Body Plus Nutritional Products Inc Recalls of Precision Extreme Mega Test

    19 Apr 2017

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/body-plus-nutritional-products-inc-recalls-of-precision-extreme-mega-test-1492664564.pdf

    HEALTH CANADA
    19 Apr 2017
    Share Share
    Oral hesperidin—Amorphization and improved dissolution properties
    Oral hesperidin—Amorphization and improved dissolution properties

    23 Nov 2016

    // PHARMA EXCIPIENTS

    http://www.pharma-excipients.ch/2016/11/22/oral-hesperidin-amorphization-and-improved-dissolution-properties-by-controlled-loading-onto-porous-silica/

    PHARMA EXCIPIENTS
    23 Nov 2016
    Share Share